Nationwide Surveillance Study of Vancomycin-Intermediate Staphylococcus aureus Strains in Korean Hospitals from 2001 to 2006 |
Chung, Gyung-Tae
(Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health)
Cha, Jeong-Ok (Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health) Han, Sun-Young (Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health) Jang, Hee-Sun (Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health) Lee, Kyeong-Min (Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health) Yoo, Jae-Il (Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health) Yoo, Jeong-Sik (Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health) Kim, Hong-Bin (Department of Internal Medicine, Seoul National University College of Medicine) Eun, Soo-Hoon (Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health) Kim, Bong-Su (Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health) Park, Ok (Infectious Disease Surveillance Team, Korea Center for Disease Control and Prevention) Lee, Yeong-Seon (Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health) |
1 | Goldstein, F. 2007. The potential clinical impact of low-level antibiotic resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 59: 1-4. |
2 | Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oquri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40: 135-136. DOI |
3 | Kim, M. N., S. H. Hwang, Y. J. Pyo, H. M. Mun, and C. H. Pai. 2002. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J. Clin. Microbiol. 40: 1376-1380. DOI ScienceOn |
4 | Marchese, A., G. Balistreri, E. Tonoli, E. A. Debbla, and G. C. Schito. 2000. Heterogeneous vancomycin resistance in methicillinresistant Staphylococcus aureus strains in a large Italian hospital. J. Clin. Microbiol. 38: 866-869. |
5 | Poly, M. C., C. Grelaud, C. Martin, L. de Lumley, and F. Denis. 1998. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 351: 1212. |
6 | Clark, N. C., R. C. Cooksey, B. C. Hill, J. M. Swenson, and F. C. Tenover. 1993. Characterization of glycopeptides-resistant enterococci from U.S. hospitals. Antimicrob. Agents Chemother. 37: 2311-2317. DOI ScienceOn |
7 | Denis, O., C. Nonhoff, B. Byl, C. Knoop, S. Bobin-Dubreux, and M. J. Struelens. 2002. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: Microbiological and clinical features. J. Antimicrob. Chemother. 50: 383-391. DOI |
8 | Guerin, F., A. Buu-Hoi, J. L. Mainardi, G. Kac, N. Colardelle, S. Vaupre, L. Gutmann, and I. Podglajen. 2000. Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J. Clin. Microbiol. 38: 2985-2988. |
9 | Hussain, F. M., S. Boyle-Vavra, P. B. Shete, and R. S. Daum. 2002. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. J. Infect. Dis. 186: 661-667. DOI ScienceOn |
10 | Kim, H. B., Y. S. Lee, B. S. Kim, J. O. Cha, S. U. Kwon, H. J. Lee, et al. 2006. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml Korea. Microb. Drug Res. 12: 33-38. DOI ScienceOn |
11 | Monday, S. R. and G. A. Bohach. 1999. Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. J. Clin. Microbiol. 37: 3411-3414. |
12 | Reverdy, M. E., S. Jarraud, S. Bobin-Dubreux, E. Burel, P. Girardo, G. Lina, F. Vandenesch, and J. Etienne. 2001. Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals. Clin. Microbiol. Infect. 7: 267-272. DOI ScienceOn |
13 | Sieradzki, K., R. B. Roberts, S. W. Harber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340: 517-523. DOI ScienceOn |
14 | Lee, K., C. L. Chang, N. Y. Lee, H. S. Kim, K. S. Hong, and H. C. Cho. 2000. Korean nationwide surveillance of antimicrobial resistance of bacteria in 1998. Yonsei Med. J. 41: 497-506. |
15 | Van Griethuysen, A., A. Van't Veen, A. Buiting, T. Walsh, and J. Kluytmans. 2003. High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands. J. Clin. Microbiol. 41: 2487-2491. DOI ScienceOn |
16 | Aligholi, M., M. Emaneini, F. Jabalameli, S. Shahsavan, H. Dabiri, and H. Sedaght. 2008. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini hospital in Tahran. Med. Princ. Pract. 17: 432-434. DOI ScienceOn |
17 | Bierbaum, G., K. Fuchs, W. Lenz, C. Szekat, and H. G. Sahl. 1999. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 18: 691-696. DOI ScienceOn |
18 | Centers for Diseases Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin - United States. MMWR 51: 565-567. |
19 | Oliveira, D. C. and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46: 2155-2161. DOI ScienceOn |
20 | Cui, L., E. Tominaga, H. M. Neoh, and K. Hiramatsu. 2006. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50: 1079-1082. DOI ScienceOn |
21 | Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J. Clin. Microbiol. 33: 2233-2239. |
22 | Wootton, M., R. A. Howe, R. Hillman, T. R. Walsh, P. M. Bennett, and A. P. MacGowan. 2001. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a U.K. hospital. J. Antimicrob. Chemother. 47: 399-403. DOI |
23 | Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350: 1670-1673. DOI ScienceOn |
24 | Kim, M. N., C. H. Pai, J. H. Woo, J. S. Ryu, and K. Hiramatsu. 2000. Vancomycin-intermediate Staphylococcus aureus in Korea. J. Clin. Microbiol. 38: 3879-3881. |
25 | Lulitanond, A., C. Engchanil, P. Chaimanee, M. Vorachit, T. Ito, and H. Keiichi. 2009. The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand. J. Clin. Microbiol. 47: 2311-2316. DOI ScienceOn |
26 | Smith, T. L., M. L. Pearson, K. R. Wilcox, C. Cruz, M. V. Lancaster, B. Robinson-Dunn, et al. 1999. Emergence of Vancomycin Resistance in Staphylococcus aureus Working Group. N. Engl. J. Med. 340: 493-501. DOI ScienceOn |
27 | Roberts, J., R. Bismuth, and V. Jarlier. 2006. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: A 20 year study in a large French teaching hospital, 1983-2002. J. Antimicrob. Chemother. 57: 506-510. DOI ScienceOn |
28 | Ike, Y., Y. Arakawa, X. Ma, K. Tatewaki, M. Nagasawa, H. Tomita, K. Tanimoto, and S. Fujimoto. 2001. Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals. J. Clin. Microbiol. 39: 4445-4451. DOI ScienceOn |
29 | Centers for Diseases Control and Prevention. 1999. Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois. MMWR 48: 1165-1167. |
30 | Rybak, M. J., S. N. Leonard, K. L. Rossi, C. M. Cheung, H. S. Sadar, and R. N. Jones. 2008. Characterization of vancomycinheteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). J. Clin. Microbiol. 46: 2950-2954. DOI ScienceOn |
31 | Hanaki, H., Y. Hososaka, C. Yanagisawa, Y. Otsuka, Z. Nagasawa, T. Nakae, and K. Sunakawa. 2007. Occurrence of vancomycinintermediate-resistant Staphylococcus aureus in Japan. J. Infect. Chemother. 13: 118-121. DOI ScienceOn |
32 | Finks, J., E. Wells, T. L. Dyke, N. Husain, L. Plizga, R. Heddurshetti, et al. 2009. Vancomycin-resistant Staphylococcus aureus, Michigan, U.S.A., 2007. Emerg. Infect. Dis. 15: 943-945. DOI |
33 | Saha, B., A. K. Singh, A. Ghosh, and M. Bal. 2008. Identification and characterization of vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J. Med. Microbiol. 57: 72-79. DOI ScienceOn |
34 | Wong, S. S. Y., P. L. Ho, P. C. Y. Woo, and K. Y. Yuen. 1999. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin. Infect. Dis. 29: 760-767. DOI ScienceOn |
35 | Becker, K., R. Roth, and G. Peters. 1998. Rapid and specific detection of toxigenic Staphylococcus aureus: Use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J. Clin. Microbiol. 36: 2548-2553. |
36 | Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard 7th Ed. Document M7-A7. CLSI, Wayne, PA. |
37 | Moore, M. R., F. Perdreau-Remington, and H. F. Chambers. 2003. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob. Agents Chemother. 47: 1262-1266. DOI ScienceOn |
38 | Tiwari, H. K. and M. R. Sen. 2006. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect. Dis. 6: 156-161. DOI ScienceOn |